Delivery Order SPE2DB24D2212-SPE2DB25FHPPT
- Not listed
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $82,455.67 for ELIQUIS 5 mg tablets (60-count units) on September 2, 2025, with a completion date of September 3, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count supply) valued at $17,735.23. This firm fixed-price contract, awarded on April 22, 2025, with an ultimate completion date of April 23, 2025, represents a non-competitive delivery order issued under a larger indefinite delivery vehicle. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,768.30 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count units) under a firm fixed price contract. The award was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a non-set-aside, competitively awarded delivery order with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $49,762.80 to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count units) on July 18, 2025, with completion expected by July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. ELIQUIS is a widely-used anticoagulant medication for stroke prevention and thromboembolism...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,862.40 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract type. The award, issued on July 9, 2025, with an ultimate completion date of July 10, 2025, represents a non-set-aside competitive procurement. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) valued at $16,636.35 under a firm fixed-price contract. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery of this pharmaceutical product from its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $4,833.56. The award was made on June 26, 2025, with an ultimate completion date of June 27, 2025, and represents a competitively awarded, non-set-aside procurement. Performance of this delivery order will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,296.32 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025, and carries no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract valued at $5,192.16, with an ultimate completion date of September 2, 2025. This is a non-set-aside delivery order issued on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued against AmerisourceBergen's larger...
- SPE2DB24D2212Indefinite Delivery Contract
- SPE2DB24D2212-SPE2DB25FHPPTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count packaging) valued at $11,679.67 under a firm fixed-price contract. The award was made on April 24, 2025, with an ultimate completion date of April 25, 2025, and represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide. The IDC enables AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for ELIQUIS, an anticoagulant medication commonly used in federal military and veteran healthcare systems, exemplifies the company's role as a critical vendor within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 4/24/25 |